Declaration: IAS Aging Matters Magazine is intended for IAS private members (and therefore is not intended for the public). It focuses on the latest international nutritional, hormonal and drug therapies to help combat the signs of aging. If you continue to use this site we will assume that you have read and agreed to the full declaration.

Read the full declaration
Close up of a purple and blue peptide cell

Peptide bioregulators – the discovery of gene switches in food

November 28th, 2016

Peptide bioregulators – the discovery of gene switches in food

Photo Professor Khavinson

Today Professor Vladimir Khavinson is the President of the European Academy of Gerontology and Geriatrics, but in the 1980’s he was a Colonel in the Soviet Union military medical corps. At the time, he and his team were approached by Kremlin officials, they wanted them to find a way to protect their troops from a myriad of problems; issues such as radiation for submariners in nuclear submarines to troops that may be blinded from known, (but thankfully unused) new weapons such as battlefield lasers.

A former Soviet military secret!

What their research uncovered – that was used for two decades on many thousands of men and women – was a remarkable link between short chain peptides and DNA. This former military secret is now available to the public as peptide bioregulators. Their published research has identified that each organ / gland / tissue uses a highly specific short chain peptide, obtained from food, to act as a ‘short-cut’ to initiate protein synthesis. These peptides, unlike proteins, can enter the blood through the stomach. Through a comprehensive list of patents and even copyrighted PowerPoint slides, the Russian research group have shown that each of the concentrated peptide bioregulators so far examined, interact with particular strands of DNA – effectively and very specifically activating repair and regenerative processes.

Figure: A short-chain peptide bioregulator interacting with DNA

This is a remarkable story since what we are describing here are peptides that act as individualised gene switches. To date, they have been tested for many years on thousands of individuals, without report of any serious side effects or contraindications. We believe that they could be set to ‘out do’ stem cells. Why? Because this peptide therapy is relatively cheap, highly specific, can be taken orally and doesn’t require any suppression of the immune system to operate fully (as stem cells do).


Original material from the trials

The peptide bioregulators available via IAS are the bovine originals; sourced from carefully chosen Danish calves and processed through pharmaceutical processes and filters. They are not the synthetic versions which have not been studied/ proven. Here is what is currently available:

  1. Cerluten® is the brain peptide bioregulator.
  2. Chelohart® is the heart peptide bioregulator.
  3. Chitomur® is the bladder peptide bioregulator.
  4. Endoluten® is the pineal peptide bioregulator.
  5. Glandokort® is the adrenal peptide bioregulator.
  6. Gotratix® is the muscle peptide bioregulator.
  7. Libidon® is the prostate gland peptide bioregulator.
  8. Pielotax® is the kidney peptide bioregulator.
  9. Sigumir® is the cartilage peptide bioregulator.
  10. Suprefort® is the pancreas peptide bioregulator.
  11. Stamakort® is the stomach mucus peptide bioregulator.
  12. Svetinorm® is the liver peptide bioregulator.
  13. Taxorest® is the lung peptide bioregulator.
  14. Testoluten® is the testes peptide bioregulator
  15. Thyreogen® is the thyroid peptide bioregulator.
  16. Ventfort® is the blood vessel peptide bioregulator.
  17. Visoluten® is the retina peptide bioregulator.
  18. Vladonix® is the thymus peptide bioregulator.
  19. Zhenoluten® is the ovary peptide bioregulator.

Peptide bioregulators act as they sound- to regulate; for example, Thyreogen® the thyroid peptide would increase thyroid activity if it were too low, but decrease it if it were too high!



Doses are very dependent upon the need and unlike hormones these peptides do not have to be taken every day, hence making them a cost effective regime. A typical/ average use could be considered as follows:

  • Start with an intensive course: 2 capsules once a day for 30-days.
  • Thereafter use 2 capsules once a day for 10-days, repeat every 2, 3, 4 or even as little as 6-months.

The story of the peptide bioregulators is a remarkable one and we recommend that you to read the articles and interviews and see the video on the IAS website.



Lost your password?